These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26004773)

  • 1. Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example.
    Maru Y; Tomita T; Deguchi A; Ieguchi K; Takita M; Tsukahara F; Takemura K; Kitao A; Gusovsky F
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):83-7. PubMed ID: 26004773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formation.
    Sun S; He M; VanPatten S; Al-Abed Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3721-3730. PubMed ID: 30238832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.
    Zhang X; Cui F; Chen H; Zhang T; Yang K; Wang Y; Jiang Z; Rice KC; Watkins LR; Hutchinson MR; Li Y; Peng Y; Wang X
    J Chem Inf Model; 2018 Apr; 58(4):816-825. PubMed ID: 29518316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
    Yang H; Wang H; Ju Z; Ragab AA; Lundbäck P; Long W; Valdes-Ferrer SI; He M; Pribis JP; Li J; Lu B; Gero D; Szabo C; Antoine DJ; Harris HE; Golenbock DT; Meng J; Roth J; Chavan SS; Andersson U; Billiar TR; Tracey KJ; Al-Abed Y
    J Exp Med; 2015 Jan; 212(1):5-14. PubMed ID: 25559892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
    Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
    World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1:TLR4:MD-2 axes.
    Sun S; He M; Wang Y; Yang H; Al-Abed Y
    PLoS One; 2018; 13(2):e0193028. PubMed ID: 29447234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two modes of ligand recognition by TLRs.
    Brodsky I; Medzhitov R
    Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in silico approach towards the identification of novel inhibitors of the TLR-4 signaling pathway.
    Mahita J; Harini K; Rao Pichika M; Sowdhamini R
    J Biomol Struct Dyn; 2016 Jun; 34(6):1345-62. PubMed ID: 26264972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of toll-like receptor 4. Insights from x-ray crystallography and molecular modeling.
    Klett J; Reeves J; Oberhauser N; Pérez-Regidor L; Martín-Santamaria S
    Curr Top Med Chem; 2014; 14(23):2672-83. PubMed ID: 25515751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties.
    Liu D; Cao G; Han L; Ye Y; SiMa Y; Ge W
    Cytokine; 2016 Aug; 84():29-36. PubMed ID: 27235587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance.
    He M; Bianchi ME; Coleman TR; Tracey KJ; Al-Abed Y
    Mol Med; 2018 May; 24(1):21. PubMed ID: 30134799
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chu M; Zhou M; Jiang C; Chen X; Guo L; Zhang M; Chu Z; Wang Y
    Front Immunol; 2018; 9():862. PubMed ID: 29922279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of the anti-inflammatory activity of novel 8-quinolinesulfonamide derivatives as TLR4/MD-2 inhibitors with efficacy in adjuvant-induced arthritis.
    Liu T; Xing S; Du J; Wang M; Han J; Li Z
    Bioorg Chem; 2021 Sep; 114():105037. PubMed ID: 34120022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel function of TLR4 in mediating the immunomodulatory effect of Benzanthrone, an environmental pollutant.
    Tewari P; Mandal P; Roy R; Asthana S; Dwivedi PD; Das M; Tripathi A
    Toxicol Lett; 2017 Jul; 276():69-84. PubMed ID: 28495615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Inflammation Driven by HMGB1.
    Yang H; Wang H; Andersson U
    Front Immunol; 2020; 11():484. PubMed ID: 32265930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Approaches to Toll-Like Receptor 4 Modulation.
    Billod JM; Lacetera A; Guzmán-Caldentey J; Martín-Santamaría S
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 signaling: a potential therapeutic target in ischemic coronary artery disease.
    Jia SJ; Niu PP; Cong JZ; Zhang BK; Zhao M
    Int Immunopharmacol; 2014 Nov; 23(1):54-9. PubMed ID: 25158302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
    Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
    Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.
    Sestito SE; Facchini FA; Morbioli I; Billod JM; Martin-Santamaria S; Casnati A; Sansone F; Peri F
    J Med Chem; 2017 Jun; 60(12):4882-4892. PubMed ID: 28471658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.